Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (415) 476-5777 Click to print page  Print

Browse Trials

In response to COVID-19, some breast cancer trials have temporarily stopped enrolling new patients. Use the contact information in our trial listings to call or email the research site for information about a trial's status.

Visit COVID-19 & Cancer Clinical Trials on Metastatic Trial Talk for regularly updated information about clinical trials during the coronavirus pandemic.

Currently viewing trials
(Last updated: May 21, 2020)

Zip Code:

Narrow my choices:

Radius (miles): All U.S.

20 All U.S.
Early stage    Advanced 
Treatment    Non-treatment 
Phase    I     II     III 
Display Only New Trials 



Hormone Therapy

Radiation Oncology


Surgery: Reconstruction

Targeted Therapy: All

Targeted Therapy: Anti-HER2 Therapy

Targeted Therapy: CDK Inhibitors

Targeted Therapy: PARP Inhibitors

Targeted Therapy: Tumor Mutations

Targeted Therapy: Other Targeted Therapy

Vaccines and Immunotherapy

Other Treatment



Complementary and Alternative Medicine

Decision Support

Diagnosing Breast Cancer

Genetics/Family History

Having Children


Managing Side Effects

No Travel Required

Predicting Response to Treatment

Preventing Breast Cancer

Preventing Recurrence





NEAREST SITE: 533 miles
OHSU Knight Cancer Institute

VISITS: Number of visits varies based upon assigned treatment


NCT ID: NCT03878524

A Personalized Medicine Study for Patients With Metastatic Breast Cancer (SMMART, Basket Study)

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) Trial Scientific Title

To assess the safety and feasibility of having a tumor board select therapy combinations for each individual patient.
Who is this for?
People with metastatic (stage IV) breast cancer.    Full eligibility criteria
Contact research site

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will undergo the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Biopsy</li> <li class="seamTextUnorderedListItem">Your tumor sample will be tested to identify biomarkers</li> <li class="seamTextUnorderedListItem">You will be assigned to a specific treatment group with a combination of two drugs selected from 35 drugs</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">You may repeat this process if you disease progresses or if you could not tolerate the assigned treatment.</i> </p> <p class="seamTextPara"> <i class="seamTextEmphasis">These 35 drugs are: Abiraterone, Enzalutamide, Venetoclax, Palbociclib, All-Trans Retinoic Acid, Bortezomib, Cabazitaxel, Oxaliplatin, Fluorouracil, Folinic Acid, Carboplatin, Panobinostat, Vorinostat, Pembrolizumab, Bevacizumab, Ipilimumab, Nivolumab, Everolimus, Sirolimus, Celecoxib, Olaparib, Afatinib, Cabozantinib, Sorafenib, Dasatinib, Erlotinib, Idelalisib, Imatinib, Lenvatinib, Pertuzumab, Ponatinib, Ruxolitinib, Sunitinib, Trametinib, Vemurafenib </i></p>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The tumor board will make a personalized treatment decision by evaluating the tumor's genetic profile. </li> <li class="seamTextUnorderedListItem">The board will choose among 35 types of targeted therapy, immunotherapy, or chemotherapy. </li> <li class="seamTextUnorderedListItem">This study also is enrolling patients with other types of cancer. </li> <li class="seamTextUnorderedListItem">This type of study is called a basket trial.</li> <li class="seamTextUnorderedListItem">Targets or mutations: ABL, BCL2, BRAF, CDK4, CDK6, COX-2, CSF-1R, CTLA-4, EGF, EGFR, FGFR, FLT3, HDAC, HER2, JAK1/2, KIT, MEK, MET, mTOR, PARP, PD-1, PDGFR, PI3Kdelta, RAF, RET, VEGF, VEGF ligand, VEGFR</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03878524' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.ohsu.edu/spatial-systems-biomedicine-center/serial-measurements-molecular-and-architectural-responses' target='_blank'>Oregon Health & Science University: SMMART program</a> </li><li class='seamTextUnorderedListItem'><a href='https://news.ohsu.edu/2018/11/16/making-cancer-clinical-trials-smmart' target='_blank'>Oregon Health & Science University NEWS: Making cancer clinical trials SMMART</a> </li></ul>
See more